Aristotle Capital Boston, LLC Pet Iq, Inc. Call Options Transaction History
Aristotle Capital Boston, LLC
- $2.9 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PETQ
# of Institutions
175Shares Held
26.6MCall Options Held
78.8KPut Options Held
111K-
Black Rock Inc. New York, NY3.01MShares$93.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.19MShares$67.9 Million0.0% of portfolio
-
Eos Management, L.P.1.97MShares$61.1 Million17.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.24MShares$38.3 Million0.01% of portfolio
-
Boston Partners Boston, MA1.04MShares$32.2 Million0.03% of portfolio
About PetIQ, Inc.
- Ticker PETQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,312,800
- Market Cap $908M
- Description
- PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...